The First Clinical Study for our Device
In May 2021, we received approval from Medicines Health products Regulatory Agency ('MHRA') for the initiation of the first clinical study for our groundbreaking uterine sensing device and biosensing data platform.
Partnering with London Women’s Clinic
We're excited to announce our second product collaboration agreement with one of the UK’s leading fertility clinics.
Verso Biosense signs agreement with Homerton University Hospital
We are delighted to announce the signing of a product collaboration agreement with Homerton University Hospital.